in this issue
Regions :: Western Europe :: Germany
Merck KGaA to invest $55 million to build pharma facility
December 12, 2013 | Deepti Ramesh
Merck KGaA says that it has begun construction on a new pharmaceutical production facility at Reinbek near Hamburg, Germany, for its Allergopharma unit. The new facility will involve an investment of about €40 million ($55 million) and will be used to expand production to serve new markets such as China, the company says. Construction is expected to be completed in 2016, and the facility will produce products for the diagnosis and treatment of type 1 allergies such as hay fever or allergic asthma. Allergopharma was founded in 1969. Merck has been the largest...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be: